Finding Description
Based on observation, interview, and record review, the facility failed to ensure a medication error rate of less than 5%, when 3 errors were observed during 35 opportunities resulting in an error rate of 8.57% related to not administering medication in accordance with physician's orders and manufactures instructions for 3 of 3 residents observed for insulin administration (Residents 20, 17, and 9).
Findings include:
During a random continuous observation, on 7/26/23 from 11:25 a.m. to 12:44 p.m., Registered Nurse (RN) 11 indicated there were 4 residents with orders for blood glucose monitoring using a glucose meter and insulin coverage before lunch. Resident 24 was observed to refuse to have her blood sugar checked per glucose meter, RN 11 indicated the refusal was normal for this resident.
1. On 7/20/23 at 12:41 p.m., RN 11 was observed preparing a glucose meter and Novolog flex pen (a rapid-acting insulin available in a disposable insulin pen with a push-button extension) for Resident 20. RN 11 indicated the resident had always done his own blood sugar check and given his own insulin as he did not like the staff poking him. RN 11 gave Resident 20 the glucose meter, and observed as he checked his glucose, the reading was 259 (normal range for an adult per the American Diabetic Association 70-99).
RN 11 was observed to prepare a Novolog flex pen, indicated the resident was to receive 11 units (U) per the routine dose, and due to his high blood sugar reading would get an additional 6 U. RN prepared the flex pen by putting a needle on the opened pen, dialed up the dosage, and handed the flex pen and alcohol prep pad to the resident. RN 11 observed the resident as he cleaned the skin on the back of his right upper arm out of his sight, place the flex pen against his skin, pushed the button, and immediately pulled the needle back out. During this process, RN 11 was not observed to clean the end of the flex pen before putting a needle on the pen, did not prime the pen (perform an air shot by dialing up 2 U of insulin, press the button, and make sure insulin came out of the needle to assure no air bubbles and pen functional), and did not prompt the resident to hold the needle in his arm long enough to allow the insulin medication time to administer (slowly counting to 10 after pressing the dose button). Additionally, the sliding scale insulin was administered late.
Resident 20's record was reviewed on 7/27/23 at 9:54 a.m. Diagnoses on Resident 20's profile included, but were not limited to, schizophrenia (mental disorder characterized by continuous or relapsing episodes of psychosis), and type 2 diabetes mellitus (the body either doesn't produce enough insulin, or it resists insulin) with skin ulcer, diabetic kidney disease, and diabetic retinopathy (damage to the retina).
A physician's order, dated 5/5/23, indicated Novolog Flex Pen U-100 Insulin, administer insulin subcutaneous per sliding scale according to blood glucose results three times daily at 7:00 a.m., 11:00 a.m., and 4:00 p.m.
If Blood Sugar is less than 60, call MD (physician).
If Blood Sugar is 0 to 119, give 0 Units.
If Blood Sugar is 120 to 160, give 2 Units.
If Blood Sugar is 161 to 200, give 5 Units.
If Blood Sugar is 201 to 240, give 8 Units.
If Blood Sugar is greater than 240, give 11 Units.
If Blood Sugar is greater than 400, call MD.
A physician's orders, dated 5/22/23, indicated Novolog Flex Pen U-100 Insulin give 6 U subcutaneous three times a day at 7:30 a.m., 12:00 p.m., and 5:00 p.m., administer with sliding scale dosage.
A physician's order, dated 7/11/23, indicated Lantus Solostar U-100 Insulin give 13 U twice daily 6:00 a.m. - 11:00 a.m., and 6:00 p.m. - 11:00 p.m. RN 11 indicated, this insulin was administered around 5:00 a.m. by the night nurse.
Blood sugar monitoring for Resident 20, dated July 2023, indicated his blood glucose levels were documented 3 to 5 times daily, and ranged from 79 to 346. There were only 2 readings within the normal range.
Resident 20's record, dated 1/16/23 to 7/27/23, lacked documentation a medication self-administration assessment was completed. The record lacked a physician's order for self-administration of insulin, a care plan for self-administration of medication, and documentation the resident was educated on proper procedure for administering insulin with a Novolog flex pen.
A quarterly Minimum Data Set (MDS) assessment, dated 6/27/23, indicated the resident had the ability to make himself understood and to understand others. A Brief Interview for Mental Status (BIMS) score of 12 out of 15 indicated the resident had moderately impaired cognition. Documentation of 7 insulin injections were received during the last 7 days.
A care plan for Resident 20, indicated the resident was at risk for effects of hyperglycemia (blood glucose levels too high) or hypoglycemia (blood glucose levels too low) related to use of glucose lowering medication and/or diagnosis of diabetes mellitus. The goal was for the resident to not experience symptoms of hyperglycemia or hypoglycemia. Interventions included diet as ordered, document abnormal findings and notify the MD, medications as ordered, and monitor blood sugars as ordered.
During an interview, on 7/27/23 at 9:48 a.m., RN 11 indicated she was not sure if Resident 20 had a physician's order to self-administer his medications. But he would not let the staff poke him, he had done it before being admitted , and it was his choice to do his own.
During an interview on 7/27/23 at 10:20 a.m., Resident 20 was observed lying on the bed. He indicated he had been back into the facility for about 7 months. During his stay staff had allowed him to check his own blood sugars and administer his own insulin. When giving his insulin he held the needle in the skin about 2 seconds. Staff had not educated him on the use of the glucose monitor or giving his own insulin.
2. During a random insulin administration observation for Resident 17 on 7/26/23 at 11:39 a.m., RN 11 was observed to check the blood glucose level with a result on 212. She then prepared a Novolog flex pen but putting a needed onto an opened pen, dialed up 6 U of Novolog insulin, put the insulin needle into the abdomen, pushed in the plunger, and immediately pulled the needle back out. RN 11 did not clean the pen before putting on a needle, did not prime the flex pen, and when the insulin was administered she put the needle into the skin and pulled it back out in one fluid movement, not giving time for the insulin to administer.
Resident 17's record was reviewed on 7/27/23 at 10:39 a.m. Diagnoses on Resident 17's profile included, but were not limited to, type 2 diabetes mellitus with diabetic neuropathy (nerve damage that occurs with diabetes that most often affects the legs and feet).
A physician's order, dated 8/20/23, indicated to administer Novolog Flex Pen U-100 Insulin per sliding scale according to blood glucose results three times daily at 7:00 a.m., 11:00 a.m., and 4:00 p.m.
If Blood Sugar is less than 60, call MD.
If Blood Sugar is 0 to 129, give 0 Units.
If Blood Sugar is 130 to 175, give 3 Units.
If Blood Sugar is 176 to 225, give 6 Units.
If Blood Sugar is 226 to 275, give 9 Units.
If Blood Sugar is 276 to 325, give 12 Units.
If Blood Sugar is 326 to 400, give 20 Units.
If Blood Sugar is greater than 400, call MD.
Blood sugar monitoring for Resident 17, dated July 2023, indicated his blood glucose levels were documented 3 times daily, ranged from 75 to 398, and had only 5 readings within the normal range.
A quarterly MDS assessment, completed on 6/27/23, indicated the resident had the ability to make himself understood and to understand others. BIMS score 12/15 indicated moderately impaired cognition. Documentation of 7 insulin injections were received during the last 7 days.
A care plan for Resident 17, indicated the resident was at risk for effects of hyperglycemia or hypoglycemia related to use of glucose lowering medication and/or diagnosis of diabetes mellitus. The goal was for the resident to not experience symptoms of hyperglycemia or hypoglycemia. Interventions included, diet as ordered, document abnormal findings and notify the MD, medications as ordered, and monitor blood sugars as ordered.
3. During a random insulin administration observation for Resident 9 on 7/26/23 at 12:14 p.m., RN 11 was observed to check the blood glucose level with a result of 354. She then dialed up 18 U of Novolog insulin (Novolog 8 U routine and 10 U sliding scale), put the insulin needle into the abdomen, push in the plunger, and immediately pull the needle back out. She was observed to take the insulin pen out of the refrigerator and administer. It should have been used at room temperature by taking the flex pen out of the refrigerator 1 to 2 hours before use. When the insulin was administered, she put the needle into skin and pulled it out in one fluid movement, not giving time for the insulin to administer. Additionally, the medication was administered late after removing the resident from the dining room after she had already started eating.
Resident 9's record was reviewed on 7/27/23 at 11:42 a.m. Diagnoses on Resident 9's profile included, but were not limited to, Alzheimer's disease, and type 2 diabetes with kidney disease and diabetic neuropathy.
A physician's order for Resident 9, dated 7/11/23, indicated Novolog Flex Pen U-100 Insulin, administer 8 U subcutaneous three times daily at 7:00 a.m., 11:00 a.m., and 4:00 p.m. Hold if blood sugar under 120.
A physician's order for Resident 9, dated 7/18/23, indicated Novolog Flex Pen insulin, administer insulin subcutaneous per sliding scale according to blood sugar results three times daily at 7:00 a.m., 11:00 a.m., and 4:00 p.m.
If Blood Sugar is less than 60, call MD.
If Blood Sugar is 0 to 119, give 0 Units.
If Blood Sugar is 120 to 200, give 4 Units.
If Blood Sugar is 201 to 250, give 7 Units.
If Blood Sugar is greater than 250, give 10 Units.
If Blood Sugar is greater than 400, call MD.
Blood sugar monitoring for Resident 9, dated July 2023, indicated her blood glucose levels were documented 3 times daily, always documented as above normal, ranged from 102 - 544, with 3 readings over 400 on 7/7 at 544, 7/10 at 496, and 7/16 at 436.
A quarterly MDS assessment, completed on 6/21/23, indicated resident usually had the ability to make herself understood and usually to understand others. BIMS score 12/15 indicated moderately impaired cognition. Documentation of 7 insulin injections were received during the last 7 days.
A care plan for Resident 9, indicated the resident was at risk for effects of hyperglycemia or hypoglycemia related to use of glucose lowering medication and/or diagnosis of diabetes mellitus. The goal was for the resident to not experience symptoms of hyperglycemia or hypoglycemia. Interventions included, diet as ordered, document abnormal findings and notify the MD, medications as ordered, and monitor blood sugars as ordered.
During an interview on 7/27/23 at 9:40 a.m., Registered Nurse (RN) 11 indicated, at lunch time there were 6 residents that had orders for blood sugar monitoring with insulin coverage, and if she was the only nurse or working with a Qualified Medication Aide (QMA), she checked the blood sugar levels and administered the insulin for all of them. There were 3 glucose monitors that were shared between residents for blood sugar monitoring, and the residents all had flex pens with insulin. The insulin pens were kept in the medication room refrigerator before being opened. After a flex pen was opened it was stored at room temperature on the medication cart for up to 28 days. Her process for administering insulin included, put a needle on the insulin pen, dial up the amount of insulin to be administered, ask the resident where they wanted their shot, put the needle in the skin, push the dial button, hold a couple to 3 seconds, and take out the needle.
During an interview on 7/27/23 at 2:15 p.m., RN 11 indicated she had received education on use of the Novolog flex pen in the past but had not had education at this facility. She was not aware of needing to bring the flex pen up to temperature when removing from the refrigerator by waiting 1 to 2 hours before using or holding the flex pen in the skin by counting to 10, per manufacturer instructions. She thought she only needed to hold the pen in the skin for administration for 3 seconds.
During an interview on 7/27/23 at 3:45 p.m., the Executive Director (ED) indicated blood glucose monitoring and insulin administration education had been provided to staff in preparation for their annual survey, she was unable to locate documentation of the education.
On 7/27/23 at 3:45 p.m., the Regional Director of Clinical Operations (RDCO) provided a Nursing Skills Competency list, titled, Insulin Pen Administration, dated 10/2019, and indicated the competency was the one currently being used by the facility. The competency indicated, 8. Attach pen needle by twisting the needle onto end of insulin. 9. Pull off and remove outer pen needle protective cap and cover. 10. Prime the pen by dialing 2 units. 11. Push the end of the pen to push out the 2 units. [A small drop of insulin should be visible. If insulin does not appear, repeat]. 12. Dial desired insulin dosage to be administered to resident. 13. Choose an injection site. 14. Cleanse injection site with alcohol swab and allow to dry. 15. Grasp about one inch of skin between thumb and finger of non-dominant hand. 16. Insert pen needle at a 45 - 90 - degree angle into skin. 17. Push injection button down at end of pen completely to give insulin. 18. Wait 5 - 10 seconds while keeping insulin pen and pen needle in place, to ensure all insulin is given. 19. Pull the insulin pen and needle out from the injection site .
3.1-48(c)(1)